Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Net Margin Growth (3y) (2013 - 2026)

Analysis

Lemaitre Vascular (LMAT) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -641.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 420.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 484.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 459.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 941.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -1,024.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 574.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 300.00
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 807.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 807.00
Mar 31, 2026 1,073.00
Dec 31, 2025 1,088.00
Sep 30, 2025 1,446.00
Jun 30, 2025 1,310.00
Mar 31, 2025 313.00
Dec 31, 2024 363.00
Sep 30, 2024 337.00
Jun 30, 2024 77.00
Mar 31, 2024 196.00
Dec 31, 2023 -54.00
Sep 30, 2023 -481.00
Jun 30, 2023 207.00
Mar 31, 2023 244.00
Dec 31, 2022 -199.00
Sep 30, 2022 -383.00
Jun 30, 2022 -734.00
Mar 31, 2022 293.00
Dec 31, 2021 199.00
Sep 30, 2021 -90.00